ea0046p9 | (1) | UKINETS2016
Barriuso Jorge
, Lamarca Angela
, McNamara Mairead
, Burgis Timothy
, Manoharan Prakash
, Hayes Andrew
, Mansoor Wasat
, Hubner Richard
, Valle Juan
Background: Despite encouraging advances in the systemic therapy options for patients with pNETs (sunitinib and everolimus), no predictive biomarkers have been established for these drugs. We aimed to identify distinctive genomic alterations associated with benefit from treatment in patients with pNETs, by comparing exceptional-responders (ER) to poor-responders (PO).Methods: Patients who achieved an objective radiological response (complete or partial) ...